Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2,355.00    -3.00 (-0.13%)
Bid:
2,351.00
Ask:
2,352.00
Spread: 1.00 (0.043%)
Market Cap: £28.40b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Director/PDMR Shareholding

Today 08:54

RNS Number : 6521I
SSE PLC
17 June 2026
 

SSE plc

Director/PDMR Shareholding

SSE plc (the "Company") - Notification of Transactions of Directors/Persons Discharging Managerial Responsibilities and their Closely Associated Persons

(i) Deferred Bonus Scheme (DBS) - Vesting of Awards Granted 1 June 2023

On 16 June 2026, the independent Trustee of the SSE Employee Trust notified the Company that it had on 15 June 2026 transferred the following beneficial interest of Ordinary shares of 50 pence each fully paid in the Company, pursuant to awards granted on 1 June 2023 under the DBS including additional shares representing the value of reinvested dividends over the three-year period to the Directors/PDMRs listed in the table that follows. Vesting of these shares was subject to continuous employment over the three-year period from date of grant (or as provided by the DBS Plan Rules).

 

 

 

1

 

Details of the person(s) discharging managerial responsibilities/person closely associated with

a)

Name(s)

Martin Pibworth (Director)

Barry O'Regan (Director)

Chris Burchell (PDMR)

Nikki Flanders (PDMR)

Finlay McCutcheon (PDMR)

Rob McDonald (PDMR)

Sam Peacock (PDMR)

John Stewart (PDMR)

Elizabeth Tanner (PDMR)

Stephen Wheeler (PDMR)

 

2

 

Reason for the notification

a)

Position/status

As noted in 1a) above

b)

Initial notification/Amendment

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SSE plc

b)

LEI

549300KI75VYLLMSK856

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 50 pence each fully paid

ISIN: GB0007908733

b)

Nature of transaction

Vesting of Awards under the SSE plc Deferred Bonus Scheme

c)

Price(s) and volume(s)

 

 

Vesting of awards granted under the SSE plc Deferred Bonus Scheme on 15 June 2026 at a vesting price of GBP£23.6737

 

 

 

 

 

 

Executive Director/PDMR

Gross Award of Shares

 

 

 

 

Accrued Dividend Shares

 

 

 

 

 

Total Shares

 

No. Shares sold at £23.6737 to meet income tax and National Insurance liabilities

 

 

 

Net Number of Shares transferred to Participant

Martin Pibworth (Director)

13,316

1,685

15,001

7,527

7,474

Barry O'Regan (Director)

2,783

351

3,134

1,642

1,492

Chris Burchell

(PDMR)

4,913

622

5,535

2,611

2,924

Nikki Flanders

(PDMR)

2,705

342

3,047

1,438

1,609

Finlay McCutcheon

(PDMR)

2,944

372

3,316

1,664

1,652

Rob McDonald

(PDMR)

4,916

622

5,538

2,779

2,759

Sam Peacock

(PDMR)

2,494

316

2,810

1,326

1,484

John Stewart

(PDMR)

3,121

396

3,517

1,765

1,752

Elizabeth Tanner

(PDMR)

3,238

409

3,647

1,721

1,926

Stephen Wheeler

(PDMR)

4,846

613

5,459

2,860

2,599

d)

Aggregated information

- Aggregated volume

- Price

 

As noted in 4c) above

As noted in 4c) above

e)

Date of transaction

15 June 2026

f)

Place of transaction

Outside a trading venue

 

 

(ii) Performance Share Plan (PSP) - Vesting of Awards Granted 1 June 2023

On 16 June 2026 the independent Trustee of the SSE Employee Trust notified the Company that it had on 15 June 2026 transferred the beneficial interest of Ordinary shares of 50 pence each fully paid in the Company, pursuant to awards granted on 1 June 2023 under the PSP including additional shares representing the value of reinvested dividends over the three-year period to Martin Pibworth, Executive Director as per the table that follows. Vesting of these shares was subject to certain performance conditions being met at the end of the three-year performance period commencing 1 April 2023. In total 63% of the award vested for the participant. The vested shares (balance post-tax), known as "Award Shares" are subject to a further holding period and will be held under nominee in accordance with the PSP Rules.

 

 

 

1

 

Details of the person(s) discharging managerial responsibilities/person closely associated with

a)

Name(s)

Martin Pibworth (Executive Director)

 

2

 

Reason for the notification

a)

Position/status

As noted in 1a) above

b)

Initial notification/Amendment

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SSE plc

b)

LEI

549300KI75VYLLMSK856

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 50 pence each fully paid

ISIN: GB0007908733

b)

Nature of transaction

Vesting of Awards under the SSE plc Performance Share Plan.

c)

Price(s) and volume(s)

 

 

Vesting of awards granted under the SSE plc Performance Share Plan on 1 June 2023 at a vesting price of GBP£23.6737

 

 

 

 

 

 

 

 

 

 

 

 

 

Executive Director/PDMR

Gross Award of Shares

 

 

 

 

 

 

Accrued Dividend Shares

 

 

 

 

 

Total Shares vested at 63%

No. Shares sold at £23.6737 to meet income tax and National Insurance liabilities

 

 

 

 

Award Shares transferred to Nominee

Martin Pibworth

(Executive Director)

83,334

10,554

59,147

29,678

29,469

d)

Aggregated information

- Aggregated volume

- Price

 

As noted in 4c) above

As noted in 4c) above

e)

Date of transaction

15 June 2026

f)

Place of transaction

Outside a trading venue

 

 

 

(iii) Leadership Share Plan (LSP) - Vesting of Awards Granted 1 June 2023

On 16 June 2026 the independent Trustee of the SSE Employee Trust notified the Company that it had on 15 June 2026 transferred the beneficial interest of Ordinary shares of 50 pence each fully paid in the Company, pursuant to awards granted on 1 June 2023 under the LSP including additional shares representing the value of reinvested dividends over the three-year period to the Director/PDMRs listed in the table that follows. Vesting of these shares was subject to certain performance conditions being met at the end of the three-year performance period commencing 1 April 2023. In total 79% of the award vested for participants.

 

 

 

1

 

Details of the person(s) discharging managerial responsibilities/person closely associated with

a)

Name(s)

Barry O'Regan (Director)

Chris Burchell (PDMR)

Nikki Flanders (PDMR)

Finlay McCutcheon (PDMR)

Rob McDonald (PDMR)

Sam Peacock (PDMR)

John Stewart (PDMR)

Elizabeth Tanner (PDMR)

Stephen Wheeler (PDMR)

 

2

 

Reason for the notification

a)

Position/status

As noted in 1a) above

b)

Initial notification/Amendment

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SSE plc

b)

LEI

549300KI75VYLLMSK856

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 50 pence each fully paid

ISIN: GB0007908733

b)

Nature of transaction

Vesting of Awards under the SSE plc Leadership Share Plan.

c)

Price(s) and volume(s)

 

 

Vesting of awards granted under the SSE plc Leadership Share Plan on 1 June 2023 at a vesting price of GBP£23.6737

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Executive Director/PDMR

Gross Award of Shares

 

 

 

 

 

 

Accrued Dividend Shares

 

 

 

 

 

Total Shares vested at 79%

 

 

 

 

No. Shares sold at £23.6737 to meet income tax and National Insurance liabilities

 

 

 

 

 

Net Number of Shares transferred to Participant

Barry O'Regan (Director)

18,676

2,364

16,618

8,706

7,912

Chris Burchell (PDMR)

27,387

3,469

24,373

11,496

12,877

Nikki Flanders (PDMR)

16,571

2,098

14,745

6,955

7,790

Finlay McCutcheon (PDMR)

16,891

2,138

15,028

7,541

7,487

Rob McDonald (PDMR)

24,856

3,147

22,119

11,099

11,020

Sam Peacock (PDMR)

13,455

1,704

11,973

5,648

6,325

John Stewart (PDMR)

16,953

2,146

15,084

7,569

7,515

Liz Tanner (PDMR)

18,837

2,385

16,761

7,906

8,855

Stephen Wheeler (PDMR)

28,150

3,565

25,051

13,123

11,928

d)

Aggregated information

- Aggregated volume

- Price

 

As noted in 4c) above

As noted in 4c) above

e)

Date of transaction

15 June 2026

f)

Place of transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFDSWWEMSEIM
Date   Source Headline
4th Dec 20257:01 amRNSSSENT response to RIIO-T3 Final Determination
3rd Dec 202510:10 amRNSHolding(s) in Company
2nd Dec 20252:41 pmRNSHolding(s) in Company
1st Dec 20258:55 amRNSHolding(s) in Company
1st Dec 20257:00 amRNSTotal Voting Rights
28th Nov 202512:42 pmRNSHolding(s) in Company
28th Nov 202512:36 pmRNSHolding(s) in Company
28th Nov 202512:32 pmRNSDirector/PDMR Shareholding
27th Nov 20259:57 amRNSHolding(s) in Company
17th Nov 202511:30 amRNSDirector/PDMR Shareholding
14th Nov 20253:45 pmRNSDirector/PDMR Shareholding
13th Nov 20255:30 pmRNSSSE
12th Nov 20256:19 pmRNSResult of Equity Issue
12th Nov 20257:01 amRNSRetail Offer by RetailBook
12th Nov 20257:00 amRNSInterim Results
12th Nov 20257:00 amRNSPROPOSED PLACING OF NEW ORDINARY SHARES
12th Nov 20257:00 amRNSStrategic Update
7th Nov 202512:51 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
24th Oct 20252:30 pmRNSHolding(s) in Company
9th Oct 202511:42 amRNSDirector/PDMR Shareholding
7th Oct 20254:08 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSNOTIFICATION OF CLOSED PERIOD
1st Oct 20257:01 amEQSTotal Voting Rights
25th Sep 202511:00 amRNSDirector/PDMR Shareholding
22nd Sep 202511:46 amRNSDirector/PDMR Shareholding
16th Sep 202512:00 pmRNSAdditional Listing
9th Sep 20254:21 pmRNSDirector/PDMR Shareholding
1st Sep 20257:00 amEQSTVR-Total Voting Rights
29th Aug 20257:00 amRNSBlock Listing 6-Monthly Return
28th Aug 20254:56 pmRNSScrip Alternative
26th Aug 20255:33 pmRNSSSEN TRANSMISSION ISSUES NEW €750m GREEN BOND
8th Aug 202511:12 amRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202510:39 amRNSSCRIP Dividend
31st Jul 202510:38 amRNSHolding(s) in Company
29th Jul 20253:51 pmRNSHolding(s) in Company
25th Jul 202511:05 amRNSHolding(s) in Company
23rd Jul 202512:13 pmRNSHolding(s) in Company
21st Jul 20253:44 pmRNSDirector/PDMR Shareholding
21st Jul 202511:49 amRNSHolding(s) in Company
17th Jul 20253:49 pmRNSResult of AGM
17th Jul 20257:00 amRNSQ1 Trading Statement
11th Jul 202511:00 amRNSDirector/PDMR Shareholding
9th Jul 20254:38 pmRNSDirector/PDMR Shareholding
8th Jul 20255:06 pmRNSDirector/PDMR Shareholding
1st Jul 20259:58 amRNSTotal Voting Rights
1st Jul 20257:09 amRNSSSENT response to RIIO-T3 Draft Determination
13th Jun 20251:15 pmRNSPublication of Annual Report and Accounts 2025
12th Jun 20255:04 pmRNSISSUE OF HYBRID CAPITAL SECURITIES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.